Related Experiment Videos
The effects of protamine on a murine leukemia virus
British Journal of Cancer
|March 1, 1971
Abstract:
THIS STUDY INDICATED THAT: (1) i.p. inoculation of protamine into (Rauscher) leukemic mice increased their X death time, (2) protamine was more toxic for leukemic than normal mice and (3) the in vitro reaction between Rauscher virus and protamine reduced its infectivity for mice.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Biologically adaptive radiotherapy for oropharyngeal Cancer (BARitOne): An R-IDEAL stage 2a-2b technical optimisation, feasibility, and safety study - Study protocol.
Clinical and translational radiation oncology·2026
Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.
Physical review letters·2026
Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.
Physical review letters·2026
Observation of tWZ Production at the CMS Experiment.
Physical review letters·2026
Dual-oxygen pancreatic cancer organoids recapitulate basal-classical heterogeneity validated by spatial transcriptomics.
British journal of cancer·2026
A deep learning-derived risk score model from digital pathology to forecast nivolumab outcomes in gastric carcinoma.
British journal of cancer·2026
CD39+CD103+CD8+ T cells enhance neoadjuvant chemoimmunotherapy efficacy in head and neck squamous cell carcinoma.
British journal of cancer·2026
Kdm2a histone demethylase ablation restores anti-tumor immunogenicity in liver cancer.
British journal of cancer·2026
Training a phage to expand its host range: directed evolution against Staphylococcus aureus from diabetic foot infections.
Antimicrobial agents and chemotherapy·2026
IS26-mediated circular blaKPC transposon in ST2483 Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy·2026
[Advances in macrophage and neutrophil crosstalk in chronic respiratory diseases].
Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology·2026